The MHC class II molecule of the non-obese diabetic (NOD) mice, I-A g7 , is associated with susceptibility to autoimmune diabetes. To try to understand the molecular basis of this association, we analyzed the peptide binding properties and intracellular behavior of I-A g7 in comparison with other I-A haplotypes. We found that I-A g7 molecules manifested normal intracellular trafficking and lifespan, and a small but clearly detectable fraction of I-A g7 in the cells formed SDS-resistant compact dimers. The binding of an antigenic reference peptide to I-A g7 was stable and was accompanied by compact dimer formation. Our analysis of the binding specificity of I-A g7 revealed a peptide binding motif of nine amino acids with a degenerate position at P1 and three conserved anchor positions: P4, P6 and P9. An allele-specific preference for negatively charged residues was found at P9, apparently due to the presence of the rare Ser residue at position 57 of the I-A g7 β chain. These findings could have implications for the mechanisms of MHC-mediated susceptibility to autoimmune diabetes in the NOD mice.
Introduction
Mice of the non-obese diabetic (NOD) strain spontaneously specificity of I-A g7 was not obvious; moreover, the binding develop autoimmune insulitis and diabetes resembling the specificities of other mouse I-A alleles are similarly obscure (8). human autoimmune disease insulin-dependent diabetes melSecond, Carrasco-Marin et al. (9) observed that, relative to litus (1,2). Genetic analysis and studies with transgenic animals other MHC class II alleles, only a minor fraction of I-A g7 in the suggest an important role for MHC class II products in the cell is occupied by stably bound peptides as judged by SDS disease (3). The only expressed MHC class II molecule in stability analysis. These authors further suggested that the I-A g7 the NOD mouse is a unique I-A allele, I-A g7 , which appears molecule is defective in peptide binding and may be unable to essential for susceptibility to diabetes (3). The I-A g7 molecule form stable complexes with peptides. However, two facts argue is identical to another I-A allele, I-A d , except for 17 amino acid against this notion: natural peptide ligands can be isolated from substitutions in the first external domain of the β chain (4). In I-A g7 (7), and both spontaneous and induced peptide-specific particular, I-A g7 features rare His-Ser residues, in place of the CD4 ϩ T cell responses are routinely observed in NOD mice. usual Pro-Asp residues, at positions 56-57 of the β chain.
Therefore, the distinct biochemical properties of I-A g7 , possibly Interestingly, polymorphism at β57 in the MHC class II molecule contributing to the association of I-A g7 with diabetes, are poorly of the human correlates with susceptibility to diabetes and defined. To this end, we studied the peptide binding characterpemphigus vulgaris (5). Thus, the association of I-A g7 with istics and the intracellular behavior of I-A g7 in comparison with diabetes might have general implications for the associations other I-A alleles. of MHC class II products with autoimmune diseases (6).
The molecular basis of the association of I-A g7 with diabetes Methods is unknown. In this regard, two unusual properties of I-A g7 were reported. First, Reich et al. (7) noticed the uncommon Animals occurrence of negatively charged residues near the C-terminus Inbred SJL/J (H-2 s ), PL/J (H-2 u ) and C3H/HeJ (H-2 k ) were of I-A g7 -bound peptides and correlated it with the rare β56His-β57Ser residues of I-A g7 . However, an overall peptide binding obtained from Jackson (Bar Harbor, ME); BALB/c (H-2 d ) mice
were from Harlan Olac (Bicester, UK). The colony of NOD/Lt phosphate buffer (25 mM citric acid, 50 mM Na 2 HPO 4 , 150 mM NaCl), pH 5.0 or 7.2, and incubated at 37°C for (H-2 g7 ) mice, originally provided by Dr E. Leiter (Jackson), was maintained at the animal breeding center of this institute. the indicated periods. For the competition assay, a single concentration of a stimulatory peptide (1 µM for p12 and 4 µM Two-month-old diabetes-free NOD mice were used for the study.
for CP1h) and a test peptide (either a single concentration of 400-1000 µM or a dose range) were added simultaneously.
Peptides
Peptides causing no inhibition of the response (Z1a TCRβ  70 Cell labeling and immunoprecipitation appear to consist of a nine amino acid sequence with four For metabolic labeling, freshly isolated splenocytes were major anchor positions: P1, P4, P6 and P9 (10). Our preliminary resuspended (2ϫ10 7 /ml) in methionine-free DMEM supplecomputer modeling suggested that I-A g7 might have a similar mented with 10% dialyzed FCS and incubated for 1 h at motif. Therefore, we designed a set of nonamer polyAla 37°C. The cells were pulsed for indicated periods of time with peptides substituted at positions 1, 4, 6 and 9. The substitu-100 µCi/ml [ 35 S]methionine and washed twice in cold PBS. For tions were chosen to represent major classes of amino acid:
pulse-chase experiments, the pulsed cells were resuspended aliphatic (Leu), aromatic (Tyr), small polar (Thr), large polar (10 7 /ml) in complete DMEM with 10% FCS and incubated at (Gln), negatively charged (Glu) and positively charged (Lys); 37°C for the indicated periods of time. For membrane labeling, other substitutions were introduced as indicated. Preliminary viable splenocytes were isolated by centrifugation over a computer modeling of I-A g7 suggested that an Arg residue density gradient of 65% Percoll, washed in PBS and labeled would not be accommodated at either P6 or P9, but is on ice with 125 I by lactoperoxidase-catalyzed iodination. favorable at P7. Therefore, two Arg residues were introduced Labeled cells were lysed using a buffer containing 1% NPat positions 7 and 8, both to increase binding and to prevent 40, 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, possible binding frameshifts in either direction. The reference 1 mM phenylmethylsulfonyl fluoride and 10 µg/ml aprotinin. peptides were AAAAAARRE for P1 and P4, AAALAARRA for
The lysates were centrifuged at 16000 g for 30 min, and P9, and AAALAARRE for P6. Limited substitutions were also precleared with Protein A-Sepharose and then with Protein tested at positions 5 and 7 using a AAALAAAAE reference A-Sepharose precoated with rabbit anti-mouse IgG serum. peptide.
In some experiments, the protocol of Germain and Rinker (14) was used with minor modifications. Briefly, the precleared Peptide binding assay lysates were divided into aliquots and either left untreated or We measured peptide binding using a competitive inhibition adjusted to pH 5.0 by the addition of acetic acid; peptides assay of T cell line proliferation in response to a reference (200 µM) were added as indicated. The aliquots were incubpeptide presented by fixed antigen-presenting cells (11). This ated for 1 h at 4 or 37°C, centrifuged for 5 min at 16,000 g assay was used because it correlates well with a binding and neutralized when necessary. The lysates were incubated assay using purified class II molecules (11,12); in addition, with 10 µg/ml of purified anti-rat/mouse I-A mAb OX6 (15) the binding of peptides to purified I-A g7 proteins was reported and the immune complexes were precipitated using Protein Ato be difficult to measure (9). The reference peptide for binding Sepharose precoated with rabbit anti-mouse IgG1 polyclonal to I-A g7 was peptide 166-185 (EEIAQVATISANGDKDIGNI) antibodies (PharMingen, San Diego, CA). The precipitates of the mouse HSP60 protein, designated p12, which is were washed, resuspended in a sample buffer containing 2% immunogenic in NOD mice (J. Boč ková et al., in preparation).
SDS and 0.77 M 2-mercaptoethanol, and either boiled for 5 The reference peptide for binding to I-A d was peptide 458-min or incubated for 40 min at room temperature. The eluted 74 (NEDQKIGIEIIKRTLKI) of the human HSP60 protein, also proteins were analyzed by SDS-PAGE in 10% gels. The gels designated CP1h, which is immunogenic in BALB/c mice were fixed, soaked in 1 M sodium salicylate (for 35 S-containing (13) . The reference T cells were CD4 ϩ , TCRαβ ϩ long-term gels), dried and autoradiographed. Each lane represents lines specific for peptides p12 and CP1h presented by I-A g7 2ϫ10 7 splenocytes. and I-A d respectively.
Activated peritoneal macrophages were isolated from mice Computer modeling that had been injected i.p. 3 days before with 0.1 mg concanavalin A. The cells were resuspended in DMEM with
The structures of I-A g7 and of I-A g7 -peptide complexes were modeled by homology to the solved crystal structures of the 10% FCS, seeded at 10 5 /well into 96-well round-bottom plastic plates and incubated for 2 h at 37°C. The adherent human MHC class II molecule HLA-DR1 (16) and of the DR1-peptide complex (17) . The models were built using the macrophage monolayers were washed with PBS, fixed with 0.1% glutaraldehyde for 1 min, and washed with 1 M lysine/ HOMOLOGY program (Biosym Technologies, San Diego, CA) and energy minimized using the ENCAD program (18) . PBS and then with PBS. The peptides were added in citrate- 
Results
of peptide binding are similar to those observed with other MHC class II molecules (19) . The peptide binding capacity of I-A g7
To examine the specificity of peptide binding to I-A g7 , different peptides were tested for their ability to competitively To examine the ability of I-A g7 to bind peptides, we used an assay based on peptide binding to MHC class II molecules inhibit the binding of p12. Figure 1 (D) shows that a natural ligand of I-A g7 , mouse transferrin 336-349 (originally termed on the surface of fixed macrophages (11). Effective binding of a peptide is detected by the proliferation of a peptidetransferrin 55-68; ref. 7), and a previously described dominant T cell epitope, GAD 509-528 (20) , were effective (ID 50 ϭ 3 specific CD4 ϩ T cell line. Although this assay does not allow precise biochemical analysis of the peptide-MHC interaction, and 40 µM respectively). In contrast, rat ribophorin I 203-218, a natural high-affinity ligand of the Lewis rat I-A molecule the general characteristics of binding can be established. As a model peptide, we used peptide 166-185 of the mouse (11), showed poor binding (ID 50 Ͼ 500 µM), confirming the specificity of the interaction. HSP60 protein, termed p12, which is strongly immunogenic in the NOD mice (J. Boč ková et al., in preparation). Peptide
The specificity of peptide binding to I-A g7 p12 binds I-A g7 in a dose-dependent, saturable manner (Fig. 1A) . As illustrated in Fig. 1(B) , p12 manifested slow To characterize the peptide binding specificity of I-A g7 , we designed a library of nonamer polyAla peptides with a set of association with I-A g7 (t 1/2 ϭ 1.5 h) which was greatly enhanced at mildly acidic pH. Once formed, the p12-I-A g7 amino acid substitutions at P1, P4, P6 and P9. Figure 2 (A) illustrates the binding of the substituted polyAla peptides to complex appeared very stable (Fig. 1C) , as significant T cell activation was still observed after 8 days of dissociation (the I-A g7 measured in the competition binding assay. Peptide binding was done at pH 5.0. Figure 2 shows that I-A g7 has t 1/2 was estimated to be 250 h using a single exponential fit). Moreover, similar experiments using unfixed splenic antigenat least three anchor positions (P4, P6 and P9) with specific preferences for particular amino acid residues. At P4, the presenting cells revealed that p12 also persisted in living cells; Ͼ50% of the initial T cell response was still observed aliphatic Leu residue was favored; aromatic (Tyr) and small (Ala, Thr) residues were accepted, while large polar (Gln) after 24 h of dissociation (data not shown). These parameters and charged (Glu, Lys) residues decreased the binding. At Peptide binding to I-A g7 versus I-A d P6, a strong preference for small residues (Ala, Thr) was
The preference for negatively charged residues at the observed; the apparent accommodation of Glu might result C-terminal P9 anchor position appears to distinguish I-A g7 from a frameshift whereby the Glu residue actually served as from other mouse I-A alleles. To study this point, we tested anchor 9. At P9, the negatively charged Glu residue was the set of peptides substituted at P9 for their binding to the favored while all other residues interfered with binding.
highly homologous class II allele, I-A d . Indeed, a different Notably, P1 appeared to be degenerate, since all tested specificity of binding was observed in this case: the small residues could be accommodated at this position. In addition, Ala residue showed the best binding, while charged (Glu, P1 was less important for binding than the other positions, Lys) and aromatic (Tyr) residues decreased binding significsince, in contrast to P4 and P9, no significant increase in antly ( Fig. 2A) . binding was observed with any substitution at P1 (note that To confirm the correct assignment of the anchor positions the same basic polyAla peptide was used for substitutions at in the experiments described above, we tested the binding P1 and P4).
of the mouse invariant chain 85-101 (CLIP) peptide to I-A g7 Essentially the same results were obtained when the binding and I-A d . The CLIP peptide contains a nonamer 'supermotif' was performed at pH 7.2 (data not shown). However, the sequence (amino acids 90-98: MRMATPLLM) which binds preference for Glu at P9 was less pronounced at neutral pH promiscuously to different MHC class II molecules by way of and other residues except Lys were accommodated, albeit defined anchor positions (reviewed in 21). Figure 2 (B) shows less efficiently. This observation may explain the binding of that CLIP bound moderately to I-A g7 (the binding was peptides lacking an acidic residue at P9 (see below). At P6, increased at neutral pH; data not shown) while the shorter moderate binding was observed with Leu, Asn and Glu, while 89-99 peptide (sCLIP) did not bind at all. However, the Tyr, Gln and Lys abolished the binding completely.
binding of both peptides was greatly enhanced by a 98Met In addition to the P4, P6 and P9 anchor positions, other → Glu substitution at P9. In contrast, this substitution did not positions could influence peptide binding to I-A g7 in a less enhance the binding of the CLIP peptides to I-A d , consistent specific manner. Indeed, as shown on Fig. 2(A) , the introducwith a different specificity of P9 in I-A d . tion at P7 of Arg or Leu residues increased binding significMolecular modeling of I-A g7 antly. In contrast, only a moderate increase in binding was observed when these residues were placed at P5. The
The results observed above were consistent with a computer modeled structure of I-A g7 (see below) shows a large pocket model of the I-A g7 structure and its interactions with peptides. at P7, which apparently can accommodate a broad variety
The model was developed by homology to the solved crystal structure of HLA-DR1 (16) and of the DR1-peptide complex of amino acids with a preference for large side chains. In addition, the rare β56His and β57Ser residues of I-A g7 and other residues important for the specificity of P9 (β61Tyr and α76Arg) are highlighted. (17) (Fig. 3) . The modeling showed a peptide binding groove
The trafficking and peptide occupancy of I-A g7 in cells similar to that of HLA-DR1, with prominent pockets at P1, P4, To analyze the intracellular behavior and in vivo peptide P6, P7 and P9. Since the critical Asn residues (α62, α69 and occupancy of I-A g7 proteins in comparison to other I-A alleles, β82) involved in hydrogen bond formation with the peptide we immunoprecipitated I-A molecules from splenocytes of backbone are conserved in I-A g7 , the conformation of peptides different haplotypes. To facilitate the comparison, the I-A in the binding groove would appear to be similar to that found alleles were analyzed with a single mAb of broad specificity in the HLA-DR1-peptide complex. Most importantly, it is (15) that binds to I-A molecules at all stages of intracellular the rare β57Ser residue of I-A g7 that apparently confers a processing (28) . Figure 4 shows the formation of SDS-resistant preference for negatively charged residues at P9. The β57Ser compact dimers (C), the form of class II molecules characterresidue both interacts directly with the P9 side chain and istic of stable peptide binding, by metabolically labeled 'opens' the positive charge of α76Arg, which is otherwise mature I-A molecules. Note, at the top of the I-A s NB lane, involved in a salt bridge with β57Asp, at the bottom of the that I-A s molecules form high mol. wt aggregates, which might pocket. The other rare residue, β56His, in contrast, seems to represent a dimer of αβ heterodimers (29) . As reported project outside of the binding groove and is unlikely to previously (9), a larger proportion (up to 75% as estimated influence the specificity of peptide binding.
by laser densitometry) of I-A g7 molecules was unstable in SDS, compared to the other I-A alleles (see α band). However, The peptide binding motif of I-A g7 a significant fraction of SDS-resistant I-A g7 heterodimers (C) was consistently detected in these experiments. The above results suggest that I-A g7 binds peptides by way Similar results were obtained when cell surface I-A moleof a typical MHC class II binding motif (10) containing at least cules were analyzed. Figure 4 (right panel) shows that, three anchor positions P4, P6 and P9, as well as other less although the majority of surface I-A g7 were SDS-unstable, a critical positions at P1 and P7. We sought the presence of fraction of compact I-A g7 dimers could be detected as well. this proposed motif in peptides known to interact with I-A g7 , These experiments also revealed the presence of low mol. wt including natural ligands, good binders and T cell epitopes material (arrow) which might represent class II-bound pepof diabetes-related antigens in NOD mice. The binding of tides labeled during cell surface iodination (30) . Indeed, this some of these peptides to I-A g7 was confirmed using the material was not precipitated by an isotypic control mAb, had binding assay described above. Table 1 shows that the a mol. wt Ͻ3 kDa (data not shown) and did not appear when analyzed I-A g7 -binding peptides carry the proposed motif, I-A heterodimers were not disrupted (see I-A s NB lane). Note confirming the specificity of peptide binding to I-A g7 in vivo.
that this labeled material was present in the unboiled (NB) The alignment of some reported T cell epitopes (26, 27) was I-A g7 sample, suggesting that SDS-susceptible I-A g7 molemore difficult, although the assignment of putative anchor cules might still contain bound peptides, as described positions was possible in each case (not shown). However, previously for HLA-DR molecules (30) . the actual affinity of these peptide epitopes for I-A g7 is not known and might, in fact, be quite low.
To analyze the intracellular transport and to estimate the 
Peptides known to interact with I-A g7 are aligned according to the proposed binding motif. Consensus residues at the major anchor positions are highlighted in bold; accepted residues at these positions as well as other preferred residues are underlined. Residues found to be dispensable for binding or for T cell responses are in lowercase. A 'ϩ' indicates that binding was confirmed in a competition binding assay (Ͼ90% inhibition at a single peptide concentration of 400-1000 µM). The ID 50 (µM), if determined, is shown in parentheses. CPH, carboxypeptidase H; GAD, glutamic acid decarboxylase; M. t., Mycobacterium tuberculosis, HSP60, heat-shock protein of 60 kDa mol.wt a This study. lifespan of I-A g7 molecules in cells, a pulse-chase analysis sistent with its degradation in the endocytic compartment. Peptide binding, revealed by the presence of compact dimers of I-A g7 in comparison with I-A s molecules was done (Fig. 5) . It can be seen that newly synthesized I-A g7 and I-A s molecules (C), became apparent after 2 h of chase. Notably, I-A g7 molecules appeared to have as long a lifespan as did I-A s associated with the 31 and 41 kDa isoforms of the invariant chain (Ii). Subsequently, the amount of Ii decreased, con-(35-40% of α chains present after 2 h of chase were still that I-A g7 molecules are unable to bind peptides stably, have a reduced lifetime and only a negligible proportion (0-4%) detected after 18 h, as determined by laser densitometry), and both SDS-stable (C) and unstable (α and β) forms of appear as compact dimers in the cell. The discrepancy between our findings and those of Carrasco-Marin et al. could I-A g7 persisted in the cell for a comparably long time.
To directly assess the binding of peptides to I-A g7 molehave arisen due to the different reagents and experimental systems used in the two studies. Be that as it may, our cules, we used the method developed by Germain and Rinker (14) . In this system, the lysates of pulse-labeled cells are findings are consistent with the successful isolation of peptides naturally bound to I-A g7 (7). Moreover, stable peptide treated at acidic pH in the presence of peptides, which results in the dissociation of Ii and in peptide binding to newly binding to I-A g7 would be expected in view of the fact that NOD mice are capable of mounting vigorous peptide-specific synthesized empty class II molecules. We found that the dissociation of Ii is apparently caused by proteolysis rather T cell responses and of positively selecting a diverse T cell repertoire. Thus, the association of I-A g7 with diabetes cannot than by acidic pH alone, since it was abrogated in the presence of protease inhibitors leupeptin and pepstatin (B.
be attributed to faulty peptide binding alone. Similar to Carrasco-Marin et al. (9), we found that compared Reizis, unpublished). Figure 6 shows that the addition of peptide p12 induced the formation of the compact dimer form to several other I-A alleles, a relatively small fraction of I-A g7 appears as the SDS-resistant form in the cells. However, here of I-A g7 (band C) confirming the ability of I-A g7 molecules to form stable SDS-resistant complexes with peptides. Other we show that this instability of I-A g7 -peptide complexes cannot be accounted for by a general inability of I-A g7 to I-A g7 -binding peptides such as Z1a TCRβ 104-115 (Fig.  6 ) and transferrin 336-349 (data not shown) specifically bind peptides. Moreover, the SDS-unstable I-A g7 molecules apparently maintained a normal lifespan, were associated increased the amount of precipitated I-A g7 molecules (see α and β bands) without the formation of compact dimers, as with a low mol. wt material consistent with bound peptides and, unlike newly synthesized Ii-free molecules, could not be described previously for I-A d molecules (14) . These data show that I-A g7 molecules are capable of peptide binding converted to compact dimers upon addition of peptides. Therefore, our data suggest that at least some of the SDSwithout conversion to the compact dimer form. Furthermore, similar peptide treatments produced no effect on pulseunstable I-A g7 molecules might still contain bound peptides, as reported previously for other MHC class II molecules (14, 30) . chased mature I-A g7 molecules (not shown), suggesting that at least some SDS-unstable mature I-A g7 heterodimers might
The molecular basis and functional consequences of the small amount of SDS-resistant I-A g7 -peptide complexes in vivo be occupied with endogenous peptides (14) .
are not clear at present. Carrasco-Marin et al. (9) demonstrated that the small amount of the compact dimer form is Discussion not determined by the rare β57/β56 residues of I-A g7 . Similarly, we have found that the bulk of rat I-A molecule, RT1.B, is This study was undertaken to identify distinct molecular properties of the diabetes-associated mouse MHC class II expressed in the compact dimer form despite the presence, as in I-A g7 , of Ser (RT1.B l,n ) or Asp (RT1.B a ) at position β57 molecule, I-A g7 . Here we report that I-A g7 binds peptides in the stable and specific manner typical of other MHC class II (not shown). SDS-unstable class II-peptide complexes were reported to have a shorter intracellular lifespan than SDSmolecules. The binding of a model peptide to I-A g7 was stable both on fixed and on living cells, and was accompanied by stable complexes (32); therefore, one can speculate that SDS-unstable peptide-I-A g7 complexes might affect T cell the formation of SDS-resistant I-A g7 compact dimers. Some peptides were able to bind I-A g7 without inducing the formation selection in the thymus or favor a particular type of T cell responses, perhaps a predominantly T h 1 responses. However, of compact dimers, as reported for other MHC class II molecules (14, 31) . The I-A g7 molecule manifested a normal we found that SDS-unstable I-A g7 molecules persisted in the cells for a long time. In addition, the closely homologous I-A d lifespan and a small, but clearly detectable fraction of I-A g7 formed compact dimers in the cell. Our results seem to molecules are also mainly SDS-unstable (33) , suggesting that this property is not unique to I-A g7 molecules. contrast with those of Carrasco-Marin et al. (9) who reported It is possible, however, that a large fraction of I-A g7 moleoverall peptide binding motif of I-A g7 should be quite different from the motifs of other mouse class II alleles which have an cules in cells is empty. Indeed, the yield of peptides isolated from purified I-A g7 molecules was found to be very low (H.-G.
Asp residue at β57. Therefore, many peptides binding to I-A g7 , possibly including diabetogenic self-peptides, would Rammensee, pers. commun.). Furthermore, the binding of peptide p12 to I-A g7 at the surface of fixed antigen-presenting not be presented by other mouse class II molecules. Indeed, the association of different HLA-DR alleles with rheumatoid cells occurred at much lower peptide concentrations than those required for other peptide-I-A combinations (not arthritis was recently shown to correlate with their distinct binding specificities (10,36). Thus, it is likely that the peptide shown), a finding compatible with a larger fraction of empty I-A g7 at the cell surface. To explain this, one could suppose binding specificity of I-A g7 plays a major role in the association of I-A g7 with diabetes. Interestingly, the peptide binding motifs that empty I-A g7 heterodimers might be unusually stable in the absence of bound peptide. Indeed, it can be noted in of I-A g7 and of the diabetes-associated human MHC class II molecule HLA-DQA1*0301/B1*0302 (35) appear quite similar, Fig. 6 that the amount of I-A g7 heterodimer did not decrease upon the removal of Ii in the acidic environment; in contrast, possibly allowing many of the same peptides to be presented by both molecules. Thus, it is possible that diabetes in mice other I-A molecules such as I-A k and I-A s were lost under these conditions (14 and our unpublished observations). In and humans might have a similar immunopathogenesis and even might involve the same autoantigenic peptides. this regard, we noted a unique combination of residues (α66Glu/β9His) in the binding groove of I-A g7 , which could potentially form an intramolecular bond stabilizing the molec
